{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:34Z","timestamp":1786118674734,"version":"build-2736575974"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/mop.0b013e32823a3c77","type":"journal-article","created":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T04:32:06Z","timestamp":1184301126000},"page":"492-502","source":"Crossref","is-referenced-by-count":0,"title":["Immunizations, neonatal hyperbilirubinemia and animal-induced injuries"],"prefix":"10.1097","volume":"19","author":[{"given":"Sean R","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-19-20210206","first-page":"988","article-title":"National, state, and urban area vaccination coverage among children aged 19-35 months - United States, 2005.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-19-20210206","first-page":"1124","article-title":"Vaccination coverage among children entering school - United States, 2005-06 school year.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-19-20210206","doi-asserted-by":"crossref","first-page":"e610","DOI":"10.1542\/peds.2005-1373","article-title":"Severe pediatric influenza in California, 2003\u20132005: implications for immunization recommendations","volume":"117","author":"Louie","year":"2006","journal-title":"Pediatrics"},{"key":"R7-19-20210206","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1086\/507552","article-title":"Antiviral management of seasonal and pandemic influenza","volume":"194","author":"Hayden","year":"2006","journal-title":"J Infect Dis"},{"key":"R8-19-20210206","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old","volume":"296","author":"Hambidge","year":"2006","journal-title":"JAMA"},{"key":"R9-19-20210206","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"R10-19-20210206","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/01.inf.0000237829.66310.85","article-title":"Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections","volume":"25","author":"Ashkenazi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R11-19-20210206","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","article-title":"Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines","volume":"355","author":"Ohmit","year":"2006","journal-title":"N Engl J Med"},{"key":"R12-19-20210206","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/507309","article-title":"Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5\u20138-year-old children","volume":"194","author":"Neuzil","year":"2006","journal-title":"J Infect Dis"},{"key":"R13-19-20210206","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1056\/NEJMoa055414","article-title":"Effectiveness of school-based influenza vaccination","volume":"355","author":"King","year":"2006","journal-title":"N Engl J Med"},{"key":"R14-19-20210206","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1542\/peds.2006-1422","article-title":"Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study","volume":"118","author":"Jackson","year":"2006","journal-title":"Pediatrics"},{"key":"R15-19-20210206","first-page":"1329","article-title":"Brief report: influenza vaccination coverage among children aged 6-23 months: six immunization information system sentinel sites, United States, 2005-06 influenza season.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R16-19-20210206","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1542\/peds.2006-0198","article-title":"Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?","volume":"118","author":"Walter","year":"2006","journal-title":"Pediatrics"},{"key":"R17-19-20210206","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization practices (ACIP).","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-19-20210206","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3201\/eid1210.051015","article-title":"Health benefits, risks, and cost-effectiveness of influenza vaccination of children","volume":"12","author":"Prosser","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R22-19-20210206","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/bmj.38995.531701.80","article-title":"Influenza vaccination: policy versus evidence","volume":"333","author":"Jefferson","year":"2006","journal-title":"BMJ"},{"key":"R23-19-20210206","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"key":"R24-19-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1542\/peds.2006-3134","article-title":"Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.","volume":"119","year":"2007","journal-title":"Pediatrics"},{"key":"R25-19-20210206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"R26-19-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"R27-19-20210206","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-200202000-00003","article-title":"Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines","volume":"21","author":"Chang","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R28-19-20210206","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1097\/01.inf.0000142467.50724.de","article-title":"Natural rotavirus infection is not associated to intussusception in Mexican children","volume":"23","author":"Velazquez","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R29-19-20210206","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2005-1556","article-title":"Intussusception after administration of the rhesus tetravalent rotavirus vaccine (Rotashield): the search for a pathogenic mechanism","volume":"117","author":"Lynch","year":"2006","journal-title":"Pediatrics"},{"key":"R31-19-20210206","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices","volume":"55","author":"Parashar","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R32-19-20210206","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.294.2.194","article-title":"Incidence of hepatitis A in the United States in the era of vaccination","volume":"294","author":"Wasley","year":"2005","journal-title":"JAMA"},{"key":"R33-19-20210206","first-page":"1","article-title":"Centers for Disease Control and Prevention. Surveillance for acute viral hepatitis \u2013 United States, 2005","volume":"56","author":"Wasley","year":"2007","journal-title":"MMWR Surveill Summ"},{"key":"R34-19-20210206","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.inf.0000247105.45185.13","article-title":"Elimination of hepatitis A infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis A immunization program","volume":"26","author":"Belmaker","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R35-19-20210206","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1542\/peds.2006-1573","article-title":"Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States","volume":"119","author":"Rein","year":"2007","journal-title":"Pediatrics"},{"key":"R36-19-20210206","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1542\/peds.2006-1572","article-title":"The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity","volume":"119","author":"Armstrong","year":"2007","journal-title":"Pediatrics"},{"key":"R37-19-20210206","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1542\/peds.2005-2755","article-title":"Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age","volume":"118","author":"Nolan","year":"2006","journal-title":"Pediatrics"},{"issue":"RR-7","key":"R38-19-20210206","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R39-19-20210206","first-page":"E050901","article-title":"Is it time to introduce hepatitis A vaccine into routine childhood immunisations?","volume":"10","author":"Arumagan","year":"2005","journal-title":"Euro Surveill"},{"key":"R40-19-20210206","first-page":"791","article-title":"Recommendations for the use of live attenuated varicella vaccine.","volume":"95","year":"1995","journal-title":"Pediatrics"},{"key":"R41-19-20210206","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"R42-19-20210206","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","article-title":"Impact of varicella vaccination on healthcare utilization","volume":"294","author":"Zhou","year":"2005","journal-title":"JAMA"},{"key":"R43-19-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.inf.0000154323.20387.82","article-title":"Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage","volume":"24","author":"Miron","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R44-19-20210206","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"key":"R45-19-20210206","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"issue":"RR-17","key":"R47-19-20210206","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine","volume":"55","author":"Kretsinger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R48-19-20210206","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of an acellular pertussis vaccine among adolescents and adults","volume":"353","author":"Ward","year":"2005","journal-title":"N Engl J Med"},{"key":"R49-19-20210206","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","article-title":"Epidemiology of pertussis","volume":"24","author":"Tan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-3","key":"R50-19-20210206","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R51-19-20210206","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1503\/cmaj.051637","article-title":"Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children","volume":"175","author":"Vickers","year":"2006","journal-title":"CMAJ"},{"key":"R52-19-20210206","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1542\/peds.2004-2759","article-title":"Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998\u20132001","volume":"116","author":"Bisgard","year":"2005","journal-title":"Pediatrics"},{"key":"R53-19-20210206","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"118","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"key":"R54-19-20210206","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2006.10.048","article-title":"Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life","volume":"25","author":"Guiso","year":"2007","journal-title":"Vaccine"},{"key":"R55-19-20210206","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1086\/320754","article-title":"Pertussis is a frequent cause of prolonged cough illness in adults and adolescents","volume":"32","author":"Senzilet","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R56-19-20210206","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JCM.02042-06","article-title":"Multitarget PCR for diagnosis of pertussis and its clinical implications","volume":"45","author":"Qin","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R57-19-20210206","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/504803","article-title":"Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT)","volume":"43","author":"Ward","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R58-19-20210206","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI28607","article-title":"Prophylactic human papillomavirus vaccines","volume":"116","author":"Lowy","year":"2006","journal-title":"J Clin Invest"},{"key":"R60-19-20210206","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"R61-19-20210206","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"R62-19-20210206","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"R63-19-20210206","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised controlled trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"RR-2","key":"R64-19-20210206","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R65-19-20210206","first-page":"1","article-title":"12 years old girls.","volume":"18","year":"2007","journal-title":"Vaccines and Immunization News"},{"key":"R66-19-20210206","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R67-19-20210206","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1086\/425271","article-title":"Role of herd immunity in determining the effect of vaccines against sexually transmitted disease","volume":"191","author":"Garnett","year":"2005","journal-title":"J Infect Dis"},{"key":"R68-19-20210206","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMcp063561","article-title":"Prevention of meningococcal disease","volume":"355","author":"Gardner","year":"2006","journal-title":"N Engl J Med"},{"issue":"RR-7","key":"R69-19-20210206","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"R70-19-20210206","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1542\/peds.2004-2514","article-title":"Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States","volume":"115","author":"Shepard","year":"2005","journal-title":"Pediatrics"},{"key":"R72-19-20210206","first-page":"1120","article-title":"Update: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine - United States, June 2005-September 2006.","volume":"55","year":"2006","journal-title":"MMWR"},{"key":"R73-19-20210206","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R74-19-20210206","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1503\/cmaj.060328","article-title":"Incidence and causes of severe neonatal hyperbilirubinemia in Canada","volume":"175","author":"Sgro","year":"2006","journal-title":"CMAJ"},{"key":"R75-19-20210206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.1.297","article-title":"Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"R76-19-20210206","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(06)68889-2","article-title":"Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial","volume":"367","author":"Chaparro","year":"2006","journal-title":"Lancet"},{"key":"R77-19-20210206","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1542\/peds.2006-0675","article-title":"What's in a name? Physiologic and pathologic jaundice: the conundrum of defining normal bilirubin levels in the newborn","volume":"118","author":"Maisels","year":"2006","journal-title":"Pediatrics"},{"key":"R78-19-20210206","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1542\/peds.2005-0744","article-title":"Transcutaneous bilirubin levels in the first 96 h in a normal newborn population of >= 35 weeks' gestation","volume":"117","author":"Maisels","year":"2006","journal-title":"Pediatrics"},{"key":"R79-19-20210206","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1542\/peds.2005-1338","article-title":"The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system","volume":"117","author":"Eggert","year":"2006","journal-title":"Pediatrics"},{"key":"R80-19-20210206","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1552-6909.2006.00044.x","article-title":"A systems approach for neonatal hyperbilirubinemia in term and near-term newborns","volume":"35","author":"Bhutani","year":"2006","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"R81-19-20210206","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1542\/peds.2005-2084","article-title":"Unbound bilirubin and risk assessment in the jaundiced newborn: possibilities and limitations","volume":"117","author":"Hank\u00f8","year":"2006","journal-title":"Pediatrics"},{"key":"R82-19-20210206","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1542\/peds.2005-0395","article-title":"Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns","volume":"117","author":"Wennberg","year":"2006","journal-title":"Pediatrics"},{"key":"R83-19-20210206","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1542\/peds.2006-0594","article-title":"Ex uno plures: the concealed complexity of bilirubin species in neonatal blood samples","volume":"118","author":"McDonagh","year":"2006","journal-title":"Pediatrics"},{"key":"R84-19-20210206","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1542\/peds.2005-3042","article-title":"The contribution of hemolysis to early jaundice in normal newborns","volume":"118","author":"Maisels","year":"2006","journal-title":"Pediatrics"},{"key":"R85-19-20210206","first-page":"583","article-title":"Randomized controlled trial of compact fluorescent lamp versus standard phototherapy for the treatment of neonatal hyperbilirubinemia","volume":"43","author":"Sarin","year":"2006","journal-title":"Indian Pediatr"},{"key":"R86-19-20210206","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1542\/peds.2004-1807","article-title":"A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns","volume":"116","author":"Gourley","year":"2005","journal-title":"Pediatrics"},{"key":"R87-19-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MPG.0b013e31802b31f2","article-title":"Randomized, controlled trial of early intravenous nutrition for prevention of neonatal jaundice in term and near-term neonates","volume":"44","author":"Makay","year":"2007","journal-title":"J Ped Gastroenterol Nutr"},{"key":"R89-19-20210206","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1542\/peds.2005-1451","article-title":"Analysis of dog bites in children who are younger than 17 years","volume":"117","author":"Schalamon","year":"2006","journal-title":"Pediatrics"},{"key":"R90-19-20210206","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5694\/j.1326-5377.2007.tb00787.x","article-title":"Animal and human bite injuries in Victoria, 1998\u20132004","volume":"186","author":"MacBean","year":"2007","journal-title":"Med J Australia"},{"key":"R91-19-20210206","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.vaccine.2006.12.034","article-title":"Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network","volume":"25","author":"Gautret","year":"2007","journal-title":"Vaccine"},{"key":"R92-19-20210206","first-page":"62","article-title":"Rabies vaccine: update.","volume":"82","year":"2007","journal-title":"Weekly Epidemiol Rec"},{"key":"R93-19-20210206","first-page":"103","article-title":"Control and prevention of rabies in animals: paradigm shifts","volume":"125","author":"Rupprecht","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"RR-3","key":"R94-19-20210206","first-page":"1","article-title":"Compendium of animal rabies prevention and control, 2007. National Association of State Public Health Veterinarians, Inc. (NASPHV).","volume":"56","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"R95-19-20210206","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Prophylaxis against rabies","volume":"351","author":"Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"key":"R96-19-20210206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virusres.2005.03.012","article-title":"Status of oral rabies vaccination in wild carnivores in the United States","volume":"111","author":"Slate","year":"2005","journal-title":"Virus Res"},{"key":"R97-19-20210206","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1197\/j.aem.2006.10.095","article-title":"Safety and efficacy of Crotalidae polyvalent immune Fab in pediatric crotaline envenomations","volume":"14","author":"Pizon","year":"2007","journal-title":"Acad Emerg Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32823a3c77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:41:07Z","timestamp":1786034467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200708000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32823a3c77","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}